Vytrus Biotech, S.A. (FRA:V5P)
Germany flag Germany · Delayed Price · Currency is EUR
8.40
-0.15 (-1.75%)
At close: Jan 30, 2026

Vytrus Biotech Ratios and Metrics

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jan '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
69161323--
Market Cap Growth
321.10%29.02%-46.26%---
Enterprise Value
67161423--
Last Close Price
8.402.1628.0033.50--
PE Ratio
35.4615.9523.1738.81--
PS Ratio
8.562.672.695.24--
PB Ratio
7.772.232.384.94--
P/TBV Ratio
15.355.067.5914.68--
P/FCF Ratio
25.639.3516.5538.78--
P/OCF Ratio
23.398.8313.9622.90--
EV/Sales Ratio
8.332.642.915.20--
EV/EBITDA Ratio
28.4213.6722.9630.92--
EV/EBIT Ratio
32.0116.3433.8238.42--
EV/FCF Ratio
24.949.2417.9338.49--
Debt / Equity Ratio
0.160.240.390.210.220.24
Debt / EBITDA Ratio
0.601.513.491.310.941.47
Debt / FCF Ratio
0.531.022.721.634.09-
Asset Turnover
0.680.600.540.590.530.39
Inventory Turnover
1.531.070.721.021.110.59
Quick Ratio
2.792.601.900.991.922.03
Current Ratio
3.083.032.461.332.262.39
Return on Equity (ROE)
24.85%16.23%10.85%13.44%11.45%6.15%
Return on Assets (ROA)
11.04%6.02%2.92%4.99%3.82%2.15%
Return on Capital Employed (ROCE)
18.30%10.00%4.90%9.00%6.40%3.50%
Earnings Yield
2.82%6.27%4.32%2.58%--
FCF Yield
3.90%10.70%6.04%2.58%--
Buyback Yield / Dilution
--11.71%---0.43%0.92%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.